Joseph Gligorov MD, PhD

Joseph Gligorov is a Professor of Medical Oncology at the University of the Sorbonne and a Medical Practitioner in the Department of Medical Oncology at Tenon Hospital, Paris (AP-HP). He is currently the executive director of the University Institute of Cancerology AP-HP Sorbonne University, grouping treatment, education, and research on cancer within a network of 7 University Hospitals and the different departments of Sorbonne University (Sciences and Humanities). This structure takes care of more than 15,000 cancer patients each year (including more than 10,000 newly diagnosed / year) in all areas of hematology and oncology and at all ages from pediatrics to geriatrics. Regarding his clinical activity, he is co-chairing the Breast Cancer Expert Center at Tenon Hospital and is mainly involved in breast cancer treatment.

Joseph Gligorov's clinical and translational research activity is focused on breast cancer's predictive and prognostic markers. He is involved in clinical research and he is a member of several steering committees and IDMCs. He is also part of the INSERM U938 team “Cancer biology and treatments”, mainly involved in the field of breast cancer and its endocrine dependence. Joseph Gligorov is vice president of the French National College of Cancerology Education and his educational activity is focused primarily on student’s and resident’s oncology education. Moreover, he is developing Sorbonne University's new educational programs for specialized nurses in oncology and for patients in partnership with the “patient’s university”.

Prof Joseph Gligorov is in charge of the Nice - St Paul de Vence breast cancer conference and treatment guidelines, and member of different national working groups devoted to cancer treatment strategies. He is also co-founder and president of the Mediterranean Association for Radiotherapy Oncology and Medical Oncology (AROMe) devoted to cancer patient care improvement, access to innovations, and oncology education in emerging countries around the Mediterranean area. He is a member of several editorial boards, advisory committees, and national and international scientific societies. He is also ESMO and ESO core faculty member and is one of the members of the ESO-ESMO Metastatic Breast Cancer Task Force. Joseph Gligorov has published more than 300 journal articles (among them more than half Medline indexed) and participated in the editing and writing of several books.